Status:
COMPLETED
The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
University of Medicine 2, Yangon, Myanmar
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
This study aims to: 1. Determine the prevalence of Helicobacter infection in Myanmar (this would be the largest ever series in the country) 2. Determine the clinical and epidemiological associations ...
Detailed Description
There are very few published studies to examine the prevalence of Helicobacter infection in Myanmar. Two previous studies (both \< 400 participants) suggested that the prevalence was approximately 50%...
Eligibility Criteria
Inclusion
- Satisfies one of the criteria for H. pylori testing in the 2017 American College of Gastroenterology guidelines
- Informed consent
Exclusion
- No informed consent
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2019
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT04132479
Start Date
January 1 2018
End Date
April 9 2019
Last Update
October 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Insein General Hospital
Yangon, Burma, 11011